Annual ROA
-2.90%
-3.29%-843.59%
December 31, 2024
Summary
- As of March 8, 2025, VNDA annual return on assets is -2.90%, with the most recent change of -3.29% (-843.59%) on December 31, 2024.
- During the last 3 years, VNDA annual ROA has fallen by -8.78% (-149.32%).
- VNDA annual ROA is now -110.24% below its all-time high of 28.33%, reached on December 31, 2019.
Performance
VNDA ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-2.90%
-0.37%-14.62%
December 31, 2024
Summary
- As of March 8, 2025, VNDA quarterly return on assets is -2.90%, with the most recent change of -0.37% (-14.62%) on December 31, 2024.
- Over the past year, VNDA quarterly ROA has dropped by -2.14% (-281.58%).
- VNDA quarterly ROA is now -108.52% below its all-time high of 34.02%, reached on June 30, 2015.
Performance
VNDA Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
VNDA ROA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -843.6% | -281.6% |
3 y3 years | -149.3% | -281.6% |
5 y5 years | -110.2% | -281.6% |
VNDA ROA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -149.3% | at low | -149.3% | at low |
5 y | 5-year | -110.2% | at low | -110.1% | at low |
alltime | all time | -110.2% | +98.4% | -108.5% | +98.0% |
Vanda Pharmaceuticals ROA History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -2.90%(-843.6%) | -2.90%(+14.6%) |
Sep 2024 | - | -2.53%(+49.7%) |
Jun 2024 | - | -1.69%(+122.4%) |
Mar 2024 | - | -0.76%(-294.9%) |
Dec 2023 | 0.39%(-61.8%) | 0.39%(-78.9%) |
Sep 2023 | - | 1.85%(-21.6%) |
Jun 2023 | - | 2.36%(-7.8%) |
Mar 2023 | - | 2.56%(+151.0%) |
Dec 2022 | 1.02%(-82.7%) | 1.02%(-5.6%) |
Sep 2022 | - | 1.08%(-41.9%) |
Jun 2022 | - | 1.86%(-40.6%) |
Mar 2022 | - | 3.13%(-46.8%) |
Dec 2021 | 5.88%(+28.1%) | 5.88%(-5.9%) |
Sep 2021 | - | 6.25%(+2.8%) |
Jun 2021 | - | 6.08%(-0.2%) |
Mar 2021 | - | 6.09%(+31.8%) |
Dec 2020 | 4.59%(-83.8%) | 4.62%(+17.9%) |
Sep 2020 | - | 3.92%(-84.0%) |
Jun 2020 | - | 24.47%(-8.9%) |
Mar 2020 | - | 26.87%(-6.3%) |
Dec 2019 | 28.33%(+202.0%) | 28.69%(-13.1%) |
Sep 2019 | - | 33.03%(+288.1%) |
Jun 2019 | - | 8.51%(+27.8%) |
Mar 2019 | - | 6.66%(-22.4%) |
Dec 2018 | 9.38%(-225.2%) | 8.58%(+77.3%) |
Sep 2018 | - | 4.84%(+830.8%) |
Jun 2018 | - | 0.52%(-124.5%) |
Mar 2018 | - | -2.12%(-71.8%) |
Dec 2017 | -7.49%(-12.0%) | -7.51%(+9.0%) |
Sep 2017 | - | -6.89%(+39.8%) |
Jun 2017 | - | -4.93%(-23.4%) |
Mar 2017 | - | -6.44%(-25.5%) |
Dec 2016 | -8.51%(-58.9%) | -8.65%(-43.5%) |
Sep 2016 | - | -15.32%(-20.8%) |
Jun 2016 | - | -19.34%(-0.8%) |
Mar 2016 | - | -19.49%(+1.9%) |
Dec 2015 | -20.72% | -19.12%(-177.8%) |
Sep 2015 | - | 24.57%(-27.8%) |
Jun 2015 | - | 34.02%(+25.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2015 | - | 27.17%(+61.9%) |
Dec 2014 | 12.81%(-184.8%) | 16.78%(-134.3%) |
Sep 2014 | - | -48.98%(-0.4%) |
Jun 2014 | - | -49.20%(+51.2%) |
Mar 2014 | - | -32.55%(+109.1%) |
Dec 2013 | -15.10%(-16.1%) | -15.57%(+3.0%) |
Sep 2013 | - | -15.11%(+1.2%) |
Jun 2013 | - | -14.93%(-11.8%) |
Mar 2013 | - | -16.92%(-5.3%) |
Dec 2012 | -17.99%(+263.4%) | -17.86%(+14.8%) |
Sep 2012 | - | -15.56%(+15.9%) |
Jun 2012 | - | -13.42%(+44.5%) |
Mar 2012 | - | -9.29%(+90.4%) |
Dec 2011 | -4.95%(-250.9%) | -4.88%(+388.0%) |
Sep 2011 | - | -1.00%(-151.0%) |
Jun 2011 | - | 1.96%(-37.2%) |
Mar 2011 | - | 3.12%(-4.0%) |
Dec 2010 | 3.28%(-112.6%) | 3.25%(-271.1%) |
Sep 2010 | - | -1.90%(-77.6%) |
Jun 2010 | - | -8.50%(-60.6%) |
Mar 2010 | - | -21.55%(-46.7%) |
Dec 2009 | -26.02%(-62.6%) | -40.41%(-46.9%) |
Sep 2009 | - | -76.17%(+1.2%) |
Jun 2009 | - | -75.30%(+9.4%) |
Mar 2009 | - | -68.80%(-13.2%) |
Dec 2008 | -69.57%(-37.5%) | -79.27%(-6.1%) |
Sep 2008 | - | -84.45%(+1.5%) |
Jun 2008 | - | -83.20%(+11.5%) |
Mar 2008 | - | -74.62%(+18.7%) |
Dec 2007 | -111.28%(-36.9%) | -62.87%(-1.0%) |
Sep 2007 | - | -63.52%(-1.7%) |
Jun 2007 | - | -64.59%(-25.0%) |
Mar 2007 | - | -86.07%(-41.2%) |
Dec 2006 | -176.39%(+97.6%) | -146.42%(+8.3%) |
Sep 2006 | - | -135.18%(+8.8%) |
Jun 2006 | - | -124.20%(+4.7%) |
Mar 2006 | - | -118.60%(+77.5%) |
Dec 2005 | -89.28%(+67.3%) | -66.80% |
Dec 2004 | -53.37% | - |
FAQ
- What is Vanda Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual ROA year-on-year change?
- What is Vanda Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly ROA year-on-year change?
What is Vanda Pharmaceuticals annual return on assets?
The current annual ROA of VNDA is -2.90%
What is the all time high annual ROA for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual return on assets is 28.33%
What is Vanda Pharmaceuticals annual ROA year-on-year change?
Over the past year, VNDA annual return on assets has changed by -3.29% (-843.59%)
What is Vanda Pharmaceuticals quarterly return on assets?
The current quarterly ROA of VNDA is -2.90%
What is the all time high quarterly ROA for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly return on assets is 34.02%
What is Vanda Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, VNDA quarterly return on assets has changed by -2.14% (-281.58%)